Shionogi & Co., Ltd.
Records under this name other than the patents Shionogi & Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 171 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,129,385 | Substituted 5-Hydroxy-3,4,6,9,9A, 10-Hexanhydro-2H-1-OXA04A,8A-DIAZA-ANTHRACENE-6,10-Dioness now held by Viiv Healthcare Company In force · High confidence | In force | High confidence | |
| US 8,110,602 | Compounds Comprising Heterocyclic-Substituted Piperidine for Treating Pain now held by Purdue Pharma L.P. In force · High confidence | In force | High confidence | |
| US 8,846,929 | Substituted-Quinoxaline-Type Piperidine Compounds and the Uses Thereof now held by Knoa Pharma LLC In force · High confidence | In force | High confidence | |
| US 9,278,967 | Substituted-Quinoxaline-Type Piperidine Compounds and the Uses Thereof now held by Knoa Pharma LLC In force · High confidence | In force | High confidence | |
| US 9,527,840 | Substituted-Quinoxaline-Type Piperidine Compounds and the Uses Thereof now held by Knoa Pharma LLC In force · High confidence | In force | High confidence | |
| US 8,287,900 | Medicated Patch Comprising 5-Methyl-1-Phenyl-2-(1H)-PYRIDONE now held by Lead Chemical Co., Ltd. In force · High confidence | In force | High confidence | |
| US 8,568,770 | Adhesive Material Containing 5-Methyl-1-Phenyl-2-(1H)-PYRIDONE now held by Lead Chemical Co., Ltd. In force · High confidence | In force | High confidence | |
| US 8,476,271 | Substituted-Quinoxaline-Type Bridged-Piperidine Compounds as ORL-1 Modulators now held by Purdue Pharma L.P. In force · High confidence | In force | High confidence | |
| US 9,145,408 | Substituted-Quinoxaline-Type Bridged-Piperidine Compounds as ORL-1 Modulators now held by Purdue Pharma L.P. In force · Medium confidence | In force | Medium confidence | |
| US 9,890,164 | Substituted-Quinoxaline-Type Bridged-Piperidine Compounds as ORL-1 Modulators now held by Purdue Pharma L.P. In force · Medium confidence | In force | Medium confidence |